A prospective clinical trial of tumor hypoxia imaging with 18f-fluoromisonidazole positron emission tomography and computed tomography (f-miso pet/ct) before and during radiation therapy

Journal of Radiation Research

Volumn 54, Issue 6, 2013, Pages 1078-1084

  Tachibana, Izumi ^a   Nishimura, Yasumasa ^a   Shibata, Toru ^a   Kanamori, Shuichi ^a   Nakamatsu, Kiyoshi ^a   Koike, Ryuta ^a   Nishikawa, Tatsuyuki ^a   Ishikawa, Kazuki ^a   Tamura, Masaya ^a   Hosono, Makoto ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

PET CT; Reoxygenation; Tumor hypoxia

Indexed keywords

COMPUTERIZED TOMOGRAPHY; DISEASES; MUSCLE; POSITRON EMISSION TOMOGRAPHY; POSITRONS; TUMORS;

CLINICAL TRIAL; EMISSION COMPUTED; FRACTIONATED RADIATION; GASTROINTESTINAL; HEAD-AND-NECK CANCER; PET/CT; PROSPECTIVES; REOXYGENATION; STANDARD DEVIATION; TUMOR HYPOXIA;

RADIOTHERAPY;

DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; MISONIDAZOLE; RADIOPHARMACEUTICAL AGENT;

18F-MISONIDAZOLE; ADULT; AGED; CELL HYPOXIA; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; MOLECULAR IMAGING; MULTIMODAL IMAGING; NEOPLASM; PET/CT; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; PROSPECTIVE STUDY; RADIATION EXPOSURE; REOXYGENATION; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; TUMOR HYPOXIA; VERY ELDERLY; YOUNG ADULT;

18F-MISONIDAZOLE; PET/CT; REOXYGENATION; TUMOR HYPOXIA;

ADULT; AGED; AGED, 80 AND OVER; CELL HYPOXIA; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; MISONIDAZOLE; MOLECULAR IMAGING; MULTIMODAL IMAGING; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84883753045     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1093/jrr/rrt033     Document Type: Review

References (26)

1. Vaupel P, Mayer A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 2007;26:225-39
2. Asquith JC, Watts ME, Patel K et al. Electron affinic sensitization. V. Radiosensitization of hypoxic bacteria and mammalian cells in vitro by some nitroimidazoles and nitropyrazoles. Radiat Res 1974;60:108-18
3. Chapman JD, Baer K, Lee J. Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells. Cancer Res 1983;43:1523-8
4. Koh WJ, Rasey JS, Evans ML et al. Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole. Int J Radiat Oncol Biol Phys 1991;22:199-212
5. Zimny M, Gagel B, DiMartino E et al. FDG - a marker of tumour hypoxia? A comparison with [18F]fluoromisonidazole and pO2-polarography in metastatic head and neck cancer. Eur J Nucl Med Mol Imaging 2006;33:1426-31
6. von Schulthess GK, Steinert HC, Hany TF. Integrated PET/ CT: current applications and future directions. Radiology 2006;238:405-22
7. 18F]fluoro-2-deoxyglucose activity. Int J Radiat Oncol Biol Phys 2010;77:350-6
8. 18F]fluoromisonidazole: a pretherapy study of 37 patients. Int J Radiat Oncol Biol Phys 1996;36:417-28
9. 18)F]FDG PET imaging in soft tissue sarcomas: Correlation of hypoxia, metabolism and VEGF expression Eur J Nucl Med Mol Imaging 2003;30:695-704
10. Koh WJ, Rasey JS, Evans ML et al. Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole. Int J Radiat Oncol Biol Phys 1991;22:199-212
11. Eisenhauer EA, Therasse P, Bogaerts J et al. New response evaluation criteria in solid tumors: revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228-247
12. Tang G, Wang M, Tang X et al. Fully automated one-pot synthesis of [18F]fluoromisonidazole. Nucl Med Biol 2005;32:553-8
13. 18F]Fluoromisonidazole uptake on oxygen delivery and tissue oxygenation in the porcine liver. Nucl Med Biol 2000;27:693-700
14. 18F] Fluoromisonidazole uptake after neoadjuvant chemotherapy for head and neck squamous cell carcinoma. Mol Imaging Biol 2011;13:227-31
15. 18F-misonidazole and PET: changes of kinetics during radiotherapy of head-and-neck cancer. Radiother Oncol 2007;83:406-10
16. Sørensen M, Horsman MR, Cumming P et al. Effect of intratumoral heterogeneity in oxygenation status on FMISO PET, autoradiography, and electrode Po2 measurements in murine tumors. Int J Radiat Oncol Biol Phys 2005;62:854-61
17. Hall EJ. Radiobiology for the Radiologist. 6th edn. Philadelphia: Lippincott Williams and Wilkins, 2006, pp. 88-89
18. Nahmias C, Wahl LM. Reproducibility of standardized uptake value measurements determined by 18F-FDG PET in malignant tumors. J Nucl Med 2008;49:1804-08
19. Kinahan PE, Fletcher JW. Positron emission tomography- computed tomography standardized uptake values in clinical practice and assessing response to therapy. Semin Ultrasound CT MR 2010; 31:496-505
20. Park HJ, Griffin RJ, Hui S et al. Radiation-induced vascular damage in tumors: implications of vascular damage in ablative hypofractionated radiotherapy (SBRT and SRS). Radiat Res 2012;177:311-27
21. Lee NY, Mechalakos JG, Nehmeh S et al. Fluorine- 18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study. Int J Radiat Oncol Biol Phys 2008;70:2-13
22. Choi W, Lee SW, Park SH et al. Planning study for available dose of hypoxic tumor volume using fluorine-18-labeled fluoromisonidazole positron emission tomography for treatment of the head and neck cancer. Radiother Oncol 2010;97:176-82
23. Lin Z, Mechalakos J, Nehmeh S et al. The influence of changes in tumor hypoxia on dose-painting treatment plans based on 18F-FMISO positron emission tomography. Int J Radiat Oncol Biol Phys 2008;70:1219-28
24. Nehmeh SA, Lee NY, Schroder H et al. Reproducibility of intratumor distribution of 18F-fluoromisonidazole in head and neck cancer. Int J Radiat Oncol Biol Phys 2008;70:235-42
25. Dirix P, Vandecaveye V, De Keyzer F et al. Dose painting in radiotherapy for head and neck squamous cell carcinoma: value of repeated functional imaging with (18)F-FDG PET, (18)F-fluoromisonidazole PET, diffusion-weighted MRI, and dynamic contrast-enhanced MRI. J Nucl Med 2009;50:1020-7
26. Rajendran JG, Schwartz DL, O'Sullivan J et al. Tumor hypoxia imaging with [F-18]Fluoromisonidazole positron emission tomography in head and neck cancer. Clin Cancer Res 2006;12:5435-41